• Lilly Loses Bid to Escape $20M Cialis Patent Verdict
  • September 25, 2017
  • <i>Law360, New York (August 28, 2017, 6:37 PM EDT)</i>--Eli Lilly & Co. on Friday lost a post-trial attempt to invalidate a German pharmaceutical company's patent when a Texas federal court denied a motion for judgment or a new trial, leaving Lilly to pay $20 million for infringing the patent when marketing the erectile dysfunction drug Cialis to treat enlarged prostates.